Skip to main content

Table 1 Characteristics of included studies

From: Proportional modes versus pressure support ventilation: a systematic review and meta-analysis

Study/year

Country

Study type

Type of ICU/inclusion criteria

Sample size (% female)

Mean or median age

Type of experiment

Intervention

Control

Colombo/2008 [29]

Italy

Crossover

Mixed ICU/patients on partial ventilator support

14 (14.2)

55.4

Physiological/20 min

NAVA (support level was to obtain similar peak inspiratory pressure to the PSV)

PSV (support level was to obtain VT of 6–8 ml/kg PBW)

Xirouchaki/2008 [22]

Greece

Parallel

Mixed ICU/patients on CMV > 36 h and awaiting weaning

208 (33.7)

59–63

Clinical/Weaning (48 h) (weaning failure was defined as the need for switching to a controlled mode or reintubation after extubation)

PAV+

PSV

Spahija/2010 [30]

Canada

Crossover

Mixed ICU/patients on MV for ARF and ready to be wean

14 (57.1)

69.4

Physiological/10 min

NAVA (support level was to obtain similar peak inspiratory pressure to the PSV)

PSV (support level was to obtain VT of 6–8 ml/kg PBW)

Patroniti/2012 [31]

Italy

Crossover

Medical ICU/patients on MV for ARF

15 (40)

67.9

Physiological/10 min

NAVA (support level was 1 cm H2O/μV)

PSV (support level was 8 cm H2O)

Elganady/2014 [23]

Egypt

Parallel

Medical ICU/patients with acute exacerbation of COPD and on MV > 24 h

60 (18.3)

59.7

Clinical/weaning (weaning failure was defined as the need for switching to a controlled mode or reintubation after extubation)

PAV+

PSV

Doorduin/2015 [32]

Netherlands

Crossover

Medical ICU/patients on MV for ARDS

12 (16.7)

64.1

Physiological/30 min

NAVA (support level was to obtain similar peak inspiratory pressure to the PSV)

PSV (support level was to obtain VT of 6 ml/kg PBW)

Schmidt/2015 [15]

France

Crossover

Mixed ICU/patients on MV > 48 h for ARF and awaiting weaning

16 (37.5)

67

Physiological/30 min

PAV+/NAVA (support level was to obtain VT of 6–8 ml/kg PBW)

PSV (support level was to obtain VT of 6–8 ml/kg PBW)

Bosma/2016 [24]

Canada

Parallel

Mixed ICU/MV > 36 h, SBT failure

50 (50)

64.8

Clinical/weaning (weaning failure was not defined)

PAV+

PSV

Carteaux/2016 [33]

France

Crossover

Medical ICU/patients on MV and recovering from ARF

11 (54.5)

69.8

Physiological/5–10 min

NAVA (support level was 0.5 cm H2O/μV)

PSV (support level was 10 cm H2O)

Demoule/2016 [25]

France

Parallel

Multicenter (medical/mixed/surgical)/patients who required endotracheal MV > 24 h for ARF and awaiting weaning

128 (32.8)

64–66

Clinical/Weaning (14 days) (weaning failure was defined as the need for switching to a controlled mode)

NAVA

PSV

Di Mussi/2016 [26]

Italy

Parallel

Mixed ICU/patients requiring CMV > 72 h for ARF

25 (44)

68.2

Physiological/48 h

NAVA (support level was titrated according to an initial steep increase PAO and VT)

PSV (support level was to obtain VT of 5–8 ml/kg PBW)

Kuo/2016 [27]

Taiwan

Parallel

Medical ICU/patients aged ≥ 45 years, and received MV > 21 days for COPD exacerbation

33 (27.3)

77.9

Clinical/weaning (weaning failure was not defined)

NAVA

PSV

Costa/2017 [34]

Italy

Crossover

Surgical ICU/patients on partial ventilator support < 72 h

13 (23.1)

58.9

Physiological/25 min

NAVA (support level was to obtain similar VT and EAdi to the PSV)

PSV (support level was to obtain VT of 6–8 ml/kg PBW)

Ferreira/2017 [35]

Brazil

Crossover

Medical ICU/patients on MV > 48 h and considered to be ready for SBT

20 (35)

60

Physiological/30 min (SBT)

NAVA (support level was to obtain similar peak inspiratory pressure to the PSV)

PSV (support level was 5 cm H2O)

Botha/2018 [28]

Australia

Parallel

Mixed ICU/patients on CMV and suitable for > 48 h of weaning on a spontaneous mode

49 (40.8)

63

Clinical/weaning (weaning failure was defined as the need for reintubation after extubation)

PAV+

PSV

  1. ICU intensive care unit, PAV proportional assist ventilation, NAVA neurally adjusted ventilatory assist, PSV pressure support ventilation, MV mechanical ventilation, COPD chronic obstructive pulmonary disease, ARF acute respiratory failure, ARDS acute respiratory distress syndrome, SBT spontaneous breathing trial, NR not reported, CMV controlled mechanical ventilation, SBT spontaneous breathing trial, VT tidal volume, EAdi diaphragm electrical activity